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Background
Data on resistance mutations in HIV-2 infected patients
are limited. With the Global Fund Initiative a large
number of HIV-2 patients will receive ART. It is important
to monitor the response of HIV-2 infected patients to ART
and to study their resistance profiles. Developing cheaper
and more sustainable assays are a priority, especially in
resource-poor settings.
Materials and methods
A cohort of 8 treatment-naïve HIV-2 infected patients
received ART and was studied longitudinally for about 7
years; clinical, immunological, virological and data were
collected. The entire HIV-2 protease and RT was ampli-
fied, sequenced and analysed for several time points. An
Oligonucleotide Ligation Assay (OLA) was developed for
the detection of resistance mutations.
Results
The mutations M184V (7/8), Q151M (1/8), K65R (1/8)
mutations were observed. HIV-2 OLA was successfully
developed for M184V, a classic Lamivudine mutation and
for Q151M, a multi-drug resistance mutation.
Conclusion
We identified important HIV-2 mutations and developed
a simple, economical and sustainable HIV-2 OLA for the
detection of these resistance mutations.
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